Re: The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta – analysis.

To the Editor:

We read the article by Tsoumpou et al. (1) with interest and commend the authors’ attempt to address this topical issue. The decision on what to do with regard to endometriomas in women having IVF remains an everyday challenge. The authors have done well to summarize the available data addressing this issue.

Acupuncture and IVF trial

I have some real concerns about the implications and conclusions drawn from the study of Domar et al. (1).

This study explores the effects of one protocol on IVF treatment. The study was indeed attempting to make sure that this was as close to the same protocol as used in the 2002 study.

Comment on “Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization.”

To the Editor:

We would like to make some comments on the paper by Onalan et al (1). In this paper, the authors found that obesity could be a factor in initiating the growth of an endometrial polyp because they identified obesity as the only independent risk factor using logistic regression analysis.

Is perifollicular vascularity assessment always feasible and clinically effective?

To the Editor:

We read with great interest the recent paper by Robson et al. (1). The authors described their experience on power Doppler assessment of perifollicular vascularity (PV) at the time of ultrasound-guided transvaginal oocyte retrieval in infertile patients who underwent in vitro fertilization (IVF) showing that this procedure is practical and reproducible, and concluding that it should be tested in larger studies in order to define its clinical value.

Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation

To the Editor:

I read with interest the article by Doody, et al (1). The literature support for the need for luteal support in IVF was presented by Daya and Gunby.(2) A recent reanalysis (3) of this meta-analysis suggests the use of vaginal progesterone to be as effective as IM Progesterone. In order to better understand this publication I seek a few points of clarification.

Lack of clinical and scientific evidence to justify the systematic use of ICSI in HIV-serodiscordant couples wishing to conceive where the male partner is infected

 

To the Editor:

 

Sauer et al. (1) reported, in a recent Fertility and Sterility issue, 10 years’ experience of an ICSI program in 181 HIV-serodiscordant couples. One hundred three deliveries were reported. It’s noteworthy that the multiple pregnancy (MP) rate was 41%, and 43% of infants were born preterm. Twenty-one infants weighed less than 1500 grams. No female HIV-seroconversions occurred.